Oman · Delayed Price · Currency is OMR Checkpoint Therapeutics Statistics
Total Valuation
MSM:MGCI has a market cap or net worth of OMR 588,326. The enterprise value is 7.50 million.
| Market Cap | 588,326 |
| Enterprise Value | 7.50M |
Important Dates
The last earnings date was Tuesday, July 15, 2025.
| Earnings Date | Jul 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MSM:MGCI has 42.02 million shares outstanding. The number of shares has increased by 4.15% in one year.
| Current Share Class | 42.02M |
| Shares Outstanding | 42.02M |
| Shares Change (YoY) | +4.15% |
| Shares Change (QoQ) | +4.37% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| PB Ratio | -0.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.73 |
| EV / Sales | 0.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -10.30% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 42,920 |
| Profits Per Employee | -6,374 |
| Employee Count | 249 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.84% in the last 52 weeks. The beta is -0.22, so MSM:MGCI's price volatility has been lower than the market average.
| Beta (5Y) | -0.22 |
| 52-Week Price Change | -54.84% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 90.96 |
| Average Volume (20 Days) | 14,326 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MSM:MGCI had revenue of OMR 10.69 million and -1.59 million in losses. Loss per share was -0.04.
| Revenue | 10.69M |
| Gross Profit | 810,548 |
| Operating Income | -1.05M |
| Pretax Income | -1.59M |
| Net Income | -1.59M |
| EBITDA | -234,654 |
| EBIT | -1.05M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 48,872 in cash and 6.96 million in debt, giving a net cash position of -6.91 million or -0.16 per share.
| Cash & Cash Equivalents | 48,872 |
| Total Debt | 6.96M |
| Net Cash | -6.91M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | -1.14M |
| Book Value Per Share | -0.03 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 7.58%, with operating and profit margins of -9.85% and -14.85%.
| Gross Margin | 7.58% |
| Operating Margin | -9.85% |
| Pretax Margin | -14.85% |
| Profit Margin | -14.85% |
| EBITDA Margin | -2.20% |
| EBIT Margin | -9.85% |
| FCF Margin | n/a |
Dividends & Yields
MSM:MGCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.15% |
| Shareholder Yield | n/a |
| Earnings Yield | -269.75% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 24, 2013. It was a forward split with a ratio of 1.1.
| Last Split Date | Mar 24, 2013 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |